by Jordana Choucair | Aug 1, 2022 | M&A
The trial seeking to prevent UnitedHealth Group from acquiring Change Healthcare will commence today. The DOJ sued to block the $8 billion acquisition, claiming the deal would hurt competition because it would give UnitedHealth too much insight about its rivals in the...
by Jordana Choucair | Aug 1, 2022 | Payers
The Centers for Medicare & Medicaid Services (CMS) announced that basic monthly Medicare premiums for Part D prescription drug coverage are estimated to be $31.50 next year, a 1.8 percent drop from this year. CMS released the rates, along with other information...
by Jordana Choucair | Jul 29, 2022 | D.C. News
Senate Majority Leader Chuck Schumer announced that Democrats will add a measure to lower insulin cost to the reconciliation package he negotiated with Senator Joe Manchin. It is unclear whether insulin cost reduction measures would survive the arcane Senate rules on...
by Jordana Choucair | Jul 29, 2022 | Life Sciences
According to Vizient’s Summer 2022 Pharmacy Market Outlook report, drug price growth will slow next year as biosimilars are expected to curb the price of the world’s best-selling drug. The report found that pharmaceutical prices are projected to increase 3.26...
by Jordana Choucair | Jul 29, 2022 | Life Sciences
he Biden administration is planning a September campaign for reformulated COVID-19 booster shots. The vaccines, which Pfizer Inc. and Moderna Inc. said they could deliver on that timeline, would be available for all adults and potentially children. The companies...
Recent Comments